CliffBio
small molecule

DICLOFENAC SODIUM

DICLOFENAC SODIUM

Loss of exclusivity—loss of exclusivity
CompanyApotex →See this company's full patent-cliff portfolio

Drug detail

Brand nameDICLOFENAC SODIUM
Active ingredientDICLOFENAC SODIUM
Strength2%
Dosage formSOLUTION
RouteTOPICAL
ModalitySmall molecule
FDA approvalMay 2022
Marketing statusRX

More from Apotex

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.